Acne Pathophysiology

  • Shinjita Das
  • Rachel ReynoldsEmail author


Acne vulgaris is the result of multifactorial processes in and around the pilosebaceous unit. Currently, the major pathogenic factors are thought to be:


Innate Immune System Congenital Adrenal Hyperplasia Sebaceous Gland Androgen Insensitivity Syndrome Acne Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Thiboutot D. Hormones and acne: pathophysiology, clinical evaluation, and therapies. Semin Cutan Med Surg. 2001;20(3):144–53.PubMedCrossRefGoogle Scholar
  2. 2.
    Thiboutot D, Jabara S, McAllister JM, Sivarajah A, Gilliland K, Cong Z, Clawson G. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003;120(6):905–14.PubMedCrossRefGoogle Scholar
  3. 3.
    Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2004;22(5):419–28. Review.PubMedCrossRefGoogle Scholar
  4. 4.
    Thiboutot D. Regulation of human sebaceous glands. J Invest Dermatol. 2004;123(1):1–12. Review.PubMedCrossRefGoogle Scholar
  5. 5.
    Plewig G, Fulton JE, Kligman AM. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch. 1971;242(1):12–29.PubMedCrossRefGoogle Scholar
  6. 6.
    Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun. 1995; 63(8):3158–65.PubMedGoogle Scholar
  7. 7.
    Guy R, Green MR, Kealey T. Modeling acne in vitro. J Invest Dermatol. 1996;106(1):176–82. PubMed PMID: 8592071.PubMedCrossRefGoogle Scholar
  8. 8.
    Parkin J, Cohen B. An overview of the immune system. Lancet. 2001;357:1777–89.PubMedCrossRefGoogle Scholar
  9. 9.
    Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001;117(1):44–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183–200. Review.PubMedGoogle Scholar
  11. 11.
    Elias PM. The skin barrier as an innate immune element. Semin Immunopathol. 2007;29(1):3–14. Review.PubMedCrossRefGoogle Scholar
  12. 12.
    Braff MH, Bardan A, Nizet V, Gallo RL. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol. 2005;125(1):9–13. Review.PubMedCrossRefGoogle Scholar
  13. 13.
    Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol. 2008;122(2):261–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344(14):1058–66. Review.PubMedCrossRefGoogle Scholar
  15. 15.
    Modlin RL, Miller LS, Bangert C, Stingl G. Innate and Adaptive Immunity in the Skin. In: Goldsmith LA, Katz SI, et al., editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York, NY: McGraw-Hill; 2012.Google Scholar
  16. 16.
    Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, Khammari A, Dreno B. Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol. 2005;153(6):1105–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211(3):193–8. Review.PubMedCrossRefGoogle Scholar
  18. 18.
    McInturff JE, Kim J. The role of toll-like receptors in the pathophysiology of acne. Semin Cutan Med Surg. 2005;24(2):73–8. Review.PubMedCrossRefGoogle Scholar
  19. 19.
    McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol. 2005;125(1):1–8. Review.PubMedCrossRefGoogle Scholar
  20. 20.
    Perisho K, Wertz PW, Madison KC, Stewart ME, Downing DT. Fatty acids of acylceramides from comedones and from the skin surface of acne patients and control subjects. J Invest Dermatol. 1988;90(3):350–3.PubMedCrossRefGoogle Scholar
  21. 21.
    Elias PM, Brown BE, Ziboh VA. The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol. 1980; 74(4):230–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol. 2003;121(1):20–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol. 2001;116(5):633–40. Review.PubMedCrossRefGoogle Scholar
  24. 24.
    Guy R, Kealey T. Modelling the infundibulum in acne. Dermatology. 1998;196(1):32–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Guy R, Kealey T. The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol. 1998;110(4):410–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21(4):363–92. Review.PubMedCrossRefGoogle Scholar
  27. 27.
    Gilliver SC, Ashworth JJ, Ashcroft GS. The hormonal regulation of cutaneous wound healing. Clin Dermatol. 2007;25(1):56–62. Review.PubMedCrossRefGoogle Scholar
  28. 28.
    Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol. 1995;105(2):209–14.PubMedCrossRefGoogle Scholar
  29. 29.
    Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365(9477):2125–36. Review.PubMedCrossRefGoogle Scholar
  30. 30.
    Lolis MS, Bowe WP, Shalita AR. Acne and systemic disease. Med Clin North Am. 2009; 93(6):1161–81.PubMedCrossRefGoogle Scholar
  31. 31.
    Maluki AH. The frequency of polycystic ovary syndrome in females with resistant acne vulgaris. J Cosmet Dermatol. 2010;9(2):142–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab. 1993;76(2):524–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Patil V, Bandivadekar A, Debjani D. Inhibition of Propionibacterium acnes lipase by extracts of Indian medicinal plants. Int J Cosmet Sci. 2012;34(3):234–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Kariya Y, Moriya T, Suzuki T, Chiba M, Ishida K, Takeyama J, Endoh M, Watanabe M, Sasano H. Sex steroid hormone receptors in human skin appendage and its neoplasms. Endocr J. 2005;52(3):317–25.PubMedCrossRefGoogle Scholar
  35. 35.
    Zouboulis CC, Korge B, Akamatsu H, Xia LQ, Schiller S, Gollnick H, Orfanos CE. Effects of 13-cis-retinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Invest Dermatol. 1991; 96(5):792–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Nelson AM, Gilliland KL, Cong Z, Thiboutot DM. 13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 2006;126(10):2178–89.PubMedCrossRefGoogle Scholar
  37. 37.
    Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta. 1996;1302(2):93–109.PubMedCrossRefGoogle Scholar
  38. 38.
    Ottaviani M, Camera E, Picardo M. Lipid mediators in acne. Mediators Inflamm 2010; 2010: 858176.Google Scholar
  39. 39.
    Zhang L, Anthonavage M, Huang Q, Li WH, Eisinger M. Proopiomelanocortin peptides and sebogenesis. Ann N Y Acad Sci. 2003;994:154–61.PubMedCrossRefGoogle Scholar
  40. 40.
    Ganceviciene R, Graziene V, Böhm M, Zouboulis CC. Increased in situ expression of melanocortin-1 receptor in sebaceous glands of lesional skin of patients with acne vulgaris. Exp Dermatol. 2007;16(7):547–52.PubMedCrossRefGoogle Scholar
  41. 41.
    Thiboutot D, Sivarajah A, Gilliland K, Cong Z, Clawson G. The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J Invest Dermatol. 2000;115(4):614–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, Scherbaum WA, Orfanos CE, McCann SM, Bornstein SR. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A. 2002;99(10):7148–53.PubMedCrossRefGoogle Scholar
  43. 43.
    Ganceviciene R, Graziene V, Fimmel S, Zouboulis CC. Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol. 2009; 160(2):345–52.PubMedCrossRefGoogle Scholar
  44. 44.
    Smith TM, Gilliland K, Clawson GA, Thiboutot D. IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol. 2008;128(5):1286–93.PubMedCrossRefGoogle Scholar
  45. 45.
    Kligman AM, Katz AG. Pathogenesis of acne vulgaris. I. Comedogenic properties of human sebum in external ear canal of the rabbit. Arch Dermatol. 1968;98(1):53–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Mills Jr OH, Kligman AM. A human model for assessing comedogenic substances. Arch Dermatol. 1982;118(11):903–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol. 1983;109(2):191–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Downing DT, Stewart ME, Wertz PW, Strauss JS. Essential fatty acids and acne. J Am Acad Dermatol. 1986;14(2 Pt 1):221–5.PubMedCrossRefGoogle Scholar
  49. 49.
    Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22(5):360–6. Review.PubMedCrossRefGoogle Scholar
  50. 50.
    Ottaviani M, Alestas T, Flori E, Mastrofrancesco A, Zouboulis CC, Picardo M. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol. 2006;126(11):2430–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med (Berl). 2006;84(1):75–87.PubMedCrossRefGoogle Scholar
  52. 52.
    Weindl G, Schäfer-Korting M, Schaller M, Korting HC. Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment? Drugs. 2005;65(14):1919–34.PubMedCrossRefGoogle Scholar
  53. 53.
    Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, Legaspi AJ, Brightbill HD, Holland D, Cunliffe WJ, Akira S, Sieling PA, Godowski PJ, Modlin RL. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169(3):1535–41.PubMedGoogle Scholar
  54. 54.
    Kuwahara K, Kitazawa T, Kitagaki H, Tsukamoto T, Kikuchi M. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci. 2005;38(1):47–55.PubMedCrossRefGoogle Scholar
  55. 55.
    Nagy I, Pivarcsi A, Koreck A, Széll M, Urbán E, Kemény L. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol. 2005;124(5):931–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A, Seltmann H, Patrick S, Zouboulis CC, Kemény L. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect. 2006;8(8):2195–205.PubMedCrossRefGoogle Scholar
  57. 57.
    Dessinioti C, Katsambas AD. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin Dermatol. 2010;28(1):2–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Jalian HR, Liu PT, Kanchanapoomi M, Phan JN, Legaspi AJ, Kim J. All-trans retinoic acid shifts Propionibacterium acnes-induced matrix degradation expression profile toward matrix preservation in human monocytes. J Invest Dermatol. 2008;128(12):2777–82.PubMedCrossRefGoogle Scholar
  59. 59.
    Choi JY, Piao MS, Lee JB, Oh JS, Kim IG, Lee SC. Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts. J Invest Dermatol. 2008;128(4):846–54.PubMedCrossRefGoogle Scholar
  60. 60.
    Chronnell CM, Ghali LR, Ali RS, Quinn AG, Holland DB, Bull JJ, Cunliffe WJ, McKay IA, Philpott MP, Müller-Röver S. Human beta defensin-1 and -2 expression in human pilosebaceous units: upregulation in acne vulgaris lesions. J Invest Dermatol. 2001;117(5):1120–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Lu PT, Phan J, Tang D, Kanchanapoomi M, Hall B, Krutzik SR, Kim J. CD209(+) macrophages mediate host defense against Propionibacterium acnes. J Immunol. 2008;180(7): 4919–23.Google Scholar
  62. 62.
    Jarrousse V, Castex-Rizzi N, Khammari A, Charveron M, Dréno B. Modulation of integrins and filaggrin expression by Propionibacterium acnes extracts on keratinocytes. Arch Dermatol Res. 2007;299(9):441–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Kurokawa I, Mayer-da-Silva A, Gollnick H, Orfanos CE. Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin. J Invest Dermatol. 1988;91(6):566–71.PubMedCrossRefGoogle Scholar
  64. 64.
    Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol. 2007;57(4):722–4.PubMedCrossRefGoogle Scholar
  65. 65.
    Holmes RL, Williams M, Cunliffe WJ. Pilo-sebaceous duct obstruction and acne. Br J Dermatol. 1972;87(4):327–32.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of DermatologyHarvard Combined Dermatology Residency ProgramBostonUSA
  2. 2.Department of DermatologyBeth Israel Deaconess Medical CenterBrooklineUSA

Personalised recommendations